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Abstract
Background:  Oesophageal carcinoma is one of the most common cancers worldwide. Its
incidence and mortality rates show a wide geographical variation at a world and regional level.
Geographic mapping of age-standardized, cause-specific death rates at a municipal level could be a
helpful and powerful tool for providing clues leading to a better understanding of its aetiology.
Methods:  This study sought to describe the geographic distribution of oesophageal cancer
mortality for Spain's 8077 towns, using the autoregressive spatial model proposed by Besag, York
and Mollié. Maps were plotted, depicting standardised mortality ratios, smoothed relative risk (RR)
estimates, and the spatial pattern of the posterior probability of RR being greater than 1.
Results: Important differences associated with area of residence were observed in risk of dying
from oesophageal cancer in Spain during the study period (1989–1998). Among men, excess risk
appeared across the north of the country, along a band spanning the length of the Cantabrian
coastline, Navarre, the north of Castile & León and the north-west of La Rioja. Excess risk was
likewise observed in the provinces of Cadiz and part of Seville in Andalusia, the islands of Tenerife
and Gran Canaria, and some towns in the Barcelona and Gerona areas. Among women, there was
a noteworthy absence of risk along the mid-section of the Cantabrian seaboard, and increases in
mortality, not observed for men, in the west of Extremadura and south-east of Andalusia.
Conclusion: These major gender- and area-related geographical differences in risk would seem to
reflect differences in the prevalence of some well-established and modifiable risk factors, including
smoking, alcohol consumption, obesity and diet. In addition, excess risks were in evidence for both
sexes in some areas, possibly suggesting the implication of certain local environmental or socio-
cultural factors. From a public health standpoint, small-area studies could be very useful for
identifying locations where epidemiological research and intervention measures ought to receive
priority, given the potential for reducing risk in certain places.
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Background
Oesophageal carcinoma is one of the most common can-
cers worldwide, ranking eighth in terms of incidence and
sixth in terms of mortality in 2002 [1]. Its incidence and
mortality rates show a wide geographical variation at an
international level, with remarkable differences between
high- and low-risk areas [1-3]. In Western countries it is a
tumour that, on the whole, is relatively infrequent in men
and very infrequent in women. However, it is an impor-
tant problem in economically less developed countries,
where the sex ratio is also much closer to unity [1].
Geographic variability is also present at a regional and
local level. In Europe, the highest incidence rates among
men appear in France and the United Kingdom, where
oesophageal cancer is 10 times more frequent than in
Greece and Macedonia [2]. Among women, the highest
rates are registered by the United Kingdom and Ireland,
while the lowest rates are recorded for Mediterranean
countries such as Greece and Spain. The most recent inci-
dence data furnished by Spanish tumour registries indi-
cate that European-population-adjusted rates range from
11.51 per 100,000 population in the Canary Islands to
4.45 in Cuenca for men, and from 1.37 in the Canary
Islands to 0.55 in Albacete for women [4]. Mortality rates
are close to those for incidence, due to the low survival for
this tumour (13% and 23% at 5 years in men and women
respectively) [5].
The main histopathologic types of oesophageal cancer are
squamous cell carcinoma (SCC) and adenocarcinoma
(AC). The dominant histological type worldwide is SCC,
tobacco and alcohol being the main agents involved in its
aetiology [6-8]. For oesophageal AC, the principal risk fac-
tors described are gastro-oesophageal reflux and obesity
[9-13]. Recent decades have witnessed a surprising
increase in the incidence of oesophageal adenocarcino-
mas in the United States and Europe [14-16], and, though
this trend might be partially explained by improvement in
the accuracy of histological diagnosis, some authors insist
that we are facing a real increase in disease burden
[17,18]. SCC, in contrast, registered a relatively stable or
declining trend in Western countries over the same time
period [14,19]. While the SCC mortality trend could be
linked to the decrease in tobacco use in the West, obesity,
gastro-oesophageal reflux disease and, possibly, reduc-
tions in Helicobacter pylori prevalence have all been sug-
gested as contributors to the upward trends in
oesophageal AC rates [20].
Despite the fact that an increased risk of oesophageal can-
cer has also been described in the offspring of affected par-
ents [21], the strong temporal and geographical
differences in incidence and mortality at a world and
regional level suggest the importance of environmental
factors in its aetiology [22]. In Spain, a previous study
highlighted the existence of important geographical dif-
ferences in mortality due to this tumour [23]. Geographic
mapping of age-standardized, cause-specific death rates
using a greater level of disaggregation could be a helpful
and powerful tool for providing clues leading to a better
understanding of its aetiology. Hence, this study set out to
analyse the spatial distribution of oesophageal cancer
mortality at a municipal level in Spain, with the aim of
highlighting interprovincial or district patterns.
Methods
Individual mortality data were used to ascertain the
number of oesophageal cancer deaths (International Clas-
sification of Diseases, 9th revision [ICD-9], code 150) for
the period 1989–1998. These data, which include infor-
mation on town or city of residence at death, were sup-
plied by the National Statistics Institute for the
production of a municipal cancer mortality atlas, after its
institutional review board approved the study. The
municipal populations, broken down by age group (18
groups) and sex, were drawn from the 1991 census and
1996 municipal roll. These years correspond to the mid-
way points of the two quinquennia that comprise the
study period (1989–1993 and 1994–1998). The person-
years for each five-year period were estimated by multiply-
ing these populations by 5.
Standardised mortality ratios (SMR) were calculated as
the ratio between observed and expected deaths. For the
calculation of expected cases, the overall Spanish mortal-
ity rates for the above two 5-year periods were applied to
each town's person-years by age group, sex and quinquen-
nium.
To draw up these maps, smoothed municipal relative risks
(RRs) were calculated using the autoregressive conditional
model initially proposed by Clayton and Kaldor [24] and
developed by Besag, York and Mollié [25]. Such models
are based on fitting spatial Poisson models with two ran-
dom-effects terms that take the following into account: a)
the effects which vary in a structured manner in space
(municipal contiguity); and, b) a component that models
the effects which vary among municipalities in an
unstructured manner (municipal heterogeneity). The
model takes the following form
Oi ~ Po(Eiλi)
log(λi) = α + hi + bi
where: λi is the relative risk in area i; Oi is the number of
deaths in area i; Ei are the expected number of cases; α is
the intercept; hi is the municipal heterogeneity term; and
bi is the spatial term.BMC Cancer 2007, 7:3 http://www.biomedcentral.com/1471-2407/7/3
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The models were fitted using bayesian Markov chain
Monte Carlo simulation methods with improper priors
[26,27]. In Bayesian modelling, prior distributions have
to be specified for all unknown parameters even when
there is no external information available. Priors, and dis-
tributions in general, are improper when they do not inte-
grate to 1. In most cases, improper priors can be used in
Bayesian analysis without major problems given that a
proper posterior distribution can be obtained [27]. Poste-
rior distributions of RR were obtained using WinBugs
[28]. The criterion of contiguity used was municipal adja-
cency.
It was possible to compile and ascertain the posterior dis-
tribution of relative risk on the basis of a single Bayesian
spatial model covering all of Spain's 8077 municipal
areas. Convergence of the simulations was verified using
the BOA (Bayesian Output Analysis) R programme library
[29]. Given the great number of parameters of the models,
the convergence analysis was performed on a randomly
selected sample of 10 towns and cities, taking strata
defined by municipal size. Convergence of the estimators
was achieved before 100,000 iterations. In the present
study, a "burn-in" (iterations discarded to ensure conver-
gence) of 300,000 iterations was performed, and the pos-
terior distribution was derived using 5,000 iterations. The
CPU time on a Pentium 2 GHz was 18 hours.
A Geographic Information System (GIS) was used to cre-
ate municipal maps of SMRs, smoothed RR estimates and
the posterior probability that RR>1.
Results
From 1989 to 1998, a total of 17618 oesophageal cancer
deaths were registered in Spain (15274 in men and 2344
in women). Table 1 displays basic descriptive statistics for
the population and disease data on both sexes.
By way of reference, Figure 1 shows the situation of
Spain's autonomous regions and provinces. Figure 2
depicts the distribution pattern of: a) SMR; and b)
smoothed RR (both sexes). The SMR map mainly shows
towns with and without cases. Despite the presence of a
greater number of towns with high risks in some areas of
the province of Cadiz, Seville or the provinces along the
Cantabrian seaboard (Bay of Biscay), in this map no clear
pattern is discernable in the distribution of risk. The
smoothed risk map, on the other hand, enables homoge-
neous areas to be more clearly delimited, showing three
areas with excess risk, namely: one in the south of main-
land Spain, in the provinces of Cadiz and Seville; one in
the north-west of the country, which basically encom-
passes the coastal provinces of Galicia, Asturias and north-
ern León; and another to the north, covering Cantabria,
the Basque Country, the north of Navarre and Burgos,
stretching down as far as La Rioja, part of Palencia, Val-
ladolid and even Segovia. Outside mainland Spain, a clear
excess risk was likewise in evidence in the Canary Islands.
Lastly, some towns in areas around Barcelona and Gerona
also registered an excess risk, albeit more moderate.
Figures 3 and 4 depict smoothed relative risk by sex and
the likelihood of the estimated RR being greater than 1. As
will be seen, the pattern plotted for men determined the
combined pattern, since the number of deaths among
men was 6-fold that of women. However, the contrast
between the maps for men and women enabled differ-
ences in the distribution of risk to be observed. Among
males, the two areas in the north of Spain that had regis-
tered excess risk for both sexes, merged and expanded to
Table 1: Summary of population and oesophageal cancer mortality in Spain's 8077 towns and cities (calendar period 1989–1998).
Total Mean Standard Deviation Median Minimum Maximum No. with zero counts
BOTH SEXES
Population 39416431 4908.85 42430.43 586 5 2866850 0
Observed 17618 2.18 19.69 0 0 1229 5029
Expected 17579.49 2.17 19.79 0.41 0.00 1346.58 0
SMR 0.77 1.74 0.00 0.00 37.02 5029
RR 0.89 0.23 0.85 0.22 2.29 0
MEN
Population 19212699 2379 20437.56 202 2 1377255 0
Observed 15274 1.89 17.02 0 0 1076 5218
Expected 14093.99 1.75 11.09 0.36 0.00 702.75 0
SMR - 0.77 1.87 0.00 0.00 40.00 5218
RR - 0.90 0.29 0.85 0.24 2.17 0
WOMEN
Population 20203732 2501 22827.22 295 1 1561416 0
Observed 2344 0.29 2.77 0 0 153 7088
Expected 2365.66 0.29 2.98 0.05 0.00 207.32 0
SMR - 0.81 4.96 0.00 0.00 166.67 7088
RR - 0.86 0.28 0.78 0.00 3.98 7BMC Cancer 2007, 7:3 http://www.biomedcentral.com/1471-2407/7/3
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include the Cantabrian coastline, from Galicia to Navarre,
and the north of the provinces of León, Palencia and Bur-
gos, whereas in women the increased risk in these regions
was far more geographically defined, with statistically sig-
nificant excess risks appearing mainly in the Galician
provinces of La Coruña (Corunna), Pontevedra and Lugo.
In the south the opposite effect took place, however, with
the excess risk observed for men in Andalusia in the prov-
inces of Cadiz and part of Seville, spreading to cover a
wider area in women, which included the western area of
the province of Malaga, the coast of Malaga and Granada,
and the west of Extremadura. A noteworthy feature in
men and women alike was the excess mortality in the
Canary Islands, which proved statistically significant in
towns on the two largest islands, Tenerife and Gran
Canaria. Finally, statistically significant RR were also in
evidence in the City of Barcelona for both sexes, and in
towns along the Barcelona coast for men.
Tables 2 and 3 show a list of towns and cities with 10 or
more deaths among men and 5 or more deaths among
women, an excess risk of over 1.5, and a posterior proba-
bility of over 0.90 that RR would be higher than 1. These
arbitrary selection criteria were used in order to select a
reasonable number of municipalities with a high and sta-
tistically significant risk excess. In line with the findings
observed in the maps, towns and cities with risks of over
1.5 were mainly situated: in the case of men, in Corunna,
Pontevedra, Guipúzcoa, Vizcaya, Asturias and the Canary
Islands; and in the case of women, in Corunna, Lugo, Viz-
caya, Cadiz, Malaga and the Canary Islands.
Discussion
This study recorded marked differences in the distribution
of oesophageal cancer mortality at a small-area level in
Spain and reveals the similarities and differences in the
patterns for men and women. Among men, mortality was
far greater in the north of the country, though an area with
excess was also detected in the south, in the provinces of
Cadiz and Seville, as well as in the Canary Islands. Among
women, the excess risk in the north of the country was
more closely delimited, and there was a noteworthy
Spanish autonomous regions and provinces Figure 1
Spanish autonomous regions and provinces.
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Municipal distribution of oesophageal cancer mortality in Spain (both sexes) Figure 2
Municipal distribution of oesophageal cancer mortality in Spain (both sexes). Distribution pattern of standardised mortality 
ratios (SMR) and smoothed relative risk (RR) under the BYM model. Spain 1989–1998.
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Municipal distribution of oesophageal cancer mortality in men: a) smoothed relative risk (RR); b) posterior probability of RR  being greater than 1 Figure 3
Municipal distribution of oesophageal cancer mortality in men: a) smoothed relative risk (RR); b) posterior probability of RR 
being greater than 1. Spain 1989–1998.
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Municipal distribution of oesophageal cancer mortality in women: a) smoothed relative risk (RR); b) posterior probability of RR  being greater than 1 Figure 4
Municipal distribution of oesophageal cancer mortality in women: a) smoothed relative risk (RR); b) posterior probability of RR 
being greater than 1. Spain 1989–1998.
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degree of excess mortality in Galicia and the south-west of
the country in particular. These results confirm the exist-
ence of some geographical risk patterns partially high-
lighted in previous studies [23], and suggest the existence
of important differences -both geographical and sex-
related- in the prevalence of some well-established and
modifiable risk factors, including smoking, alcohol con-
sumption, overweight and diet, and to some extent, differ-
ences in the distribution of the two main histological
types. Furthermore, the fact that in some areas excess risks
appear in both sexes suggests the implication of certain
local environmental or socio-cultural factors.
Disease maps typically show standardised mortality or
morbidity ratios for geographical units [30]. However, the
use of SMR for the study of spatial disease patterns in
small areas introduces an extra source of variability in the
form of random variability, since sparsely populated areas
with few or zero cases can generate extreme SMR rates
[30]. The Bayesian approach, in contrast, helps identify
Table 2: Municipalities with 10 or more observed cases of oesophageal cancer in men, RRs of over 1.50, and a posterior probability >= 
0.90 of having an RR greater than 1. Towns sorted by autonomous region and province. Spain, 1989–1998
Autonomous 
region
Province Town Observed Expected SMR RR pp(RR>1)
Andalusia Cadiz Cadiz 75 48.90 1.53 1.51 1.00
Asturias Oviedo Aller 26 8.06 3.22 1.63 1.00
Mieres del 
Camino
47 23.05 2.04 1.58 1.00
Canary Islands Palmas Arucas 17 9.69 1.76 1.50 0.99
Ingenio 17 5.83 2.92 1.94 1.00
Telde 37 20.59 1.80 1.70 1.00
Sta.Cruz de 
Tenerife
Guimar 14 5.27 2.65 1.86 1.00
Los Realejos 16 9.10 1.76 1.63 1.00
Puerto de la 
Cruz
14 8.41 1.67 1.60 0.99
Tacoronte 19 5.77 3.29 2.13 1.00
Galicia Corunna Arteixo 14 6.76 2.07 1.56 0.99
Rianxo 12 5.11 2.35 1.72 1.00
Ribeira 22 9.25 2.38 2.05 1.00
Pontevedra Cangas 13 7.71 1.69 1.66 0.99
Marín 14 7.78 1.80 1.63 1.00
Moaña 14 5.80 2.41 1.77 1.00
Mos 11 4.53 2.43 1.57 1.00
O Porriño 11 4.51 2.44 1.60 1.00
Vilagarcia de 
Arousa
16 11.34 1.41 1.54 1.00
Vilanova de 
Arousa
15 5.52 2.72 1.99 1.00
La Rioja Logroño Haro 11 3.77 2.92 1.50 1.00
Basque Country Guipúzcoa Donostia 136 67.42 2.02 1.93 1.00
Hernani 21 6.88 3.05 2.06 1.00
Irún 41 19.91 2.06 1.87 1.00
Lasarte 11 6.08 1.81 1.84 1.00
Pasaia 16 7.24 2.21 1.93 1.00
Renteria 26 14.94 1.74 1.81 1.00
Tolosa 17 7.41 2.29 1.75 1.00
Vizcaya Barakaldo 68 42.97 1.58 1.58 1.00
Bilbao 233 150.99 1.54 1.53 1.00
Leioa 14 7.55 1.86 1.60 1.00
Mungia 12 4.40 2.73 1.52 1.00
Portugalete 31 20.99 1.48 1.58 1.00
Santurtzi 40 19.02 2.10 1.90 1.00
Sestao 34 14.33 2.37 1.88 1.00
Valle de 
Trápaga
12 4.90 2.45 1.79 1.00
RR = estimated relative risk. SMR = standard mortality ratio. pp = posterior probability that RR>1.BMC Cancer 2007, 7:3 http://www.biomedcentral.com/1471-2407/7/3
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the underlying geographical pattern. Great part of the var-
iability that appears in the maps before "smoothing" is
removed by smoothing, with the result that smoothed RR
maps pinpoint high-risk areas. This approach is not free of
limitations, however, and there are authors who feel that
Bayesian disease-mapping models are essentially conserv-
ative [31].
In Spain, mortality represents the only comprehensive
and homogeneous source of information on cancer
nationwide. Oesophagus is slightly overrepresented in
Spanish mortality data, basically due to the inclusion of
adjacent gastric cancers [32]. If misclassification were
associated with geographical area, then spatial distribu-
tion of oesophageal cancer mortality could be affected by
this problem. However, death-certificate quality studies
undertaken in various regions of Spain do not suggest the
existence of important geographical differences in mis-
classification [32].
Unfortunately, available mortality data do not enable the
distribution of the main histological types in Spain to be
studied. AC and SCC, though sharing some risk factors,
display different spatial distributions and temporal trends
worldwide, denoting that they are basically different dis-
eases. Data from existing Spanish tumour registries indi-
cate that incidence of SCC is three to ten times higher than
ACC. SCC/ACC ratio do not present a clear geographical
pattern, though incidence data are not available for most
of the regions with high mortality rates in our country [4].
The implication of tobacco and alcohol in the aetiology of
SCC of the oesophagus has been highlighted by a number
of studies [6,22,33]. Risk of adenocarcinoma is also
increased by tobacco (though the association is weaker
than in the case of SCC), but there appears to be little con-
nection with alcohol consumption [6,34]. Furthermore,
combined consumption of alcohol and tobacco has a syn-
ergic effect that increases risk exponentially, not only for
oesophageal cancer, but also for other malignant
tumours, such as those of the larynx, oral cavity and phar-
ynx. The fact that in Spain the distribution of male mor-
tality due to oesophageal cancer displays similarities with
that of mortality due to the above tumours [23], with risks
excesses in south-western Andalusia, in the north of Spain
(along the central part of the Cantabrian coastline and the
Atlantic coastline of Galicia), as well as in the Canary
Islands, points to the importance of these two variables
when it comes to explaining the variability encountered in
this study among men, given that men drink and smoke
more than women [35]. In this respect, risk excesses of
dying from bladder and lung cancer have also been regis-
tered in south-western Andalusia in men, reflecting the
role of tobacco smoking in this pattern [36]. However, the
different distribution patterns of these habits [35] are not
sufficient to explain the enormous differences found
between higher- and lower-risk regions. Studies in high-
risk populations have described the implication of certain
smoking habit characteristics, such as intensity, duration,
or type of tobacco, in the geographical differences in this
tumour [37,38], as well as differences in the type of alco-
Table 3: Municipalities with 5 or more observed cases of oesophageal cancer in women, RRs of over 1.50, and a posterior probability >= 
0.90 of having an RR greater than 1. Towns sorted by autonomous region and province. Spain, 1989–1998
Autonomous region Province Town Observed Expected SMR RR pp
Andalusia Cadiz Algeciras 9 4.39 2.05 2.10 0.99
Jerez de la Frontera 23 7.93 2.90 2.24 1.00
La Línea de la Concepción 9 2.98 3.02 2.77 1.00
San Fernando 7 3.33 2.10 1.92 0.98
Malaga Benamocarra 5 0.13 37.59 3.75 1.00
Fuengirola 5 1.68 2.99 1.94 0.95
Ronda 5 1.78 2.80 1.95 1.00
Canary Islands Palmas Telde 6 2.46 2.44 1.80 0.97
Sta. Cruz de Tenerife La Laguna 8 4.51 1.78 1.73 0.97
Santa Cruz de Tenerife 17 9.73 1.75 1.75 0.99
Catalonia Barcelona Arenys de Mar 5 0.88 5.69 1.56 0.84
Galicia Corunna A Coruña (Corunna) 25 15.19 1.65 1.58 0.99
Coristanco 5 0.65 7.73 2.58 1.00
Ferrol 12 5.88 2.04 1.76 0.96
Muros 7 0.84 8.36 3.93 1.00
Santiago de Compostela 14 5.06 2.77 2.26 1.00
Teo 6 0.73 8.17 2.37 1.00
Lugo Sarriá 6 1.06 5.68 1.74 0.96
Basque Country Vizcaya Portugalete 5 2.87 1.74 1.54 0.95
Santurtzi 6 2.54 2.37 1.80 0.96
RR = estimated relative risk. SMR = standard mortality ratio. pp = posterior probability that RR>1.BMC Cancer 2007, 7:3 http://www.biomedcentral.com/1471-2407/7/3
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holic beverages consumed locally. In the Canary Islands,
moreover, existing tumour registries show the incidence
of oesophageal cancer to be the highest in Spain for men
and women alike [4], so that it would be of great interest
to study which factors might be determining such excess
risk in this area.
Gastroesophageal reflux and obesity have been described
as the strongest risk factors for oesophageal adenocarci-
noma [9-12]. Adenocarcinomas account for around 20%
of total oesophageal cancers in some Spanish tumour reg-
istries, such as Granada, Mallorca and Murcia, whereas
they represent only a 10% of cases in Navarre, Girona and
Asturias [4]. Lower exposure to alcohol and tobacco in
women could be associated with the greater relative
weight of oesophageal adenocarcinoma in Spain. In this
respect, the geographic pattern observed for women could
be partly associated with differences in the prevalence of
obese women, since Extremaduran and Andalusian
women register the greatest percentage of obesity in Spain
[33]. Galicia and the Canary Islands also have a higher
prevalence of obese women than the average level. In the
United Kingdom, which has the highest rates of female
oesophageal cancer in the EU, high body mass index in
early adulthood and low consumption of fruit were asso-
ciated with increased risk of oesophageal AC in this sex
[39], whilst no relationship with alcohol and only a mod-
erate association with smoking were found for SCC [40].
In Scotland, where the highest cumulative rates of
oesophageal adenocarcinomas in the world have been
reported [3], high rates are observed in both sexes. High
intake of saturated fats and high rates of obesity and ciga-
rette smoking have been proposed as factors that could be
implicated in these findings [41].
Insofar as diet is concerned, there is consistent evidence to
show that consumption of fruit and vegetables reduces
the risk of oesophageal cancer (both SCC and AC) [42-47]
while higher intake of dietary fat and nutrients found pri-
marily in foods of animal origin and pickled vegetables
have been associated with increased risk [44,46,48]. Some
evidence of a protective effect of olive oil [45] has been
observed, as well as a positive association with butter con-
sumption [45,49]. Furthermore, diet implies exposure to
other carcinogens ingested with foods and drinking water,
such as N-nitroso compounds [47,50,51] or diarrhetic
shellfish-poisoning toxins [52]. In France, it has been sug-
gested that differences in risk of oesophageal cancer might
be due to exposure to okadaic acid, a tumour promoter
that is the main toxin present in French coastal waters.
Regular shellfish consumers could be exposed to okadaic
acid, also detected in mussels in Galicia, a site of impor-
tant industrial mussel production [53,54]. It would be
interesting to investigate if these marine biotoxins might
be linked to the excess risk of oesophageal cancer that
appears in this and other geographical areas in our coun-
try in subsequent studies.
Similarly connected with dietary habits, consumption of
very hot beverages has also been associated with a raised
risk of oesophageal cancer in various populations, though
its role is not clear [55]. In Europe, the high incidence of
squamous cell carcinoma of the oesophagus in the
Department of Calvados, the highest risk area in France,
was attributed to the local habit of consuming hot alco-
holic beverages [49]. With regard to other hot beverages,
a recent study has suggested that tea consumption might
be the cause of the excess risk of SCC registered by women
in the United Kingdom [40]. In South America, the drink-
ing of mate, a tea-like infusion, has also been associated
with an increased risk of oesophageal SCC [56-58]. In
Spain, the role of differences in the consumption of hot
beverages in different geographical areas has not been
studied.
Social class has also been linked to the occurrence of
oesophageal cancer, with a higher incidence being
observed in groups having a low socio-economic level
[34,59]. In Western countries, low socio-economic level
reflects greater exposure to tobacco, alcohol and a worse
diet, as well as a greater likelihood of residing in more pol-
luted areas or having little access to the health system.
Brown et al [60] estimated that for SCC of the oesophagus
the combination of low income, moderate/heavy alcohol
consumption, tobacco use, and low daily consumption of
raw fruit and vegetables accounted for almost all SCC of
the oesophagus in whites (98%) and blacks (99%). They
concluded that lifestyle modifications, especially a lower
intake of alcoholic beverages, would markedly decrease
the incidence of this cancer in both races. This "clustering"
of risk factors could be linked to the excess risk detected in
Cadiz -where the highest risk of death from cancer in
Spain was already described over 15 years ago- ranking it
first for the following cancers: lung, oral cavity and phar-
ynx, oesophagus, larynx, and prostate for males; and
oesophagus, other uterus, and bone for females [61].
More recently, Benach et al [62] reported that the areas
with the highest increased risk of death in both sexes in
Spain are clustered in the south-western region of the
country, in the provinces of Huelva, Seville and Cadiz.
These authors did not elucidate the causes of this cluster-
ing of increased mortality but suggested that environmen-
tal pollution, occupational exposures and social factors
could be involved.
With regard to possible environmental factors which
might, at least in part, be determining the pattern
detected, the south-west of Andalusia is documented as
being exposed to a number of pollutants, including heavy
metals and radioactivity in water [63]. In addition, bothBMC Cancer 2007, 7:3 http://www.biomedcentral.com/1471-2407/7/3
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Galicia and Extremadura are areas with high exposure to
naturally produced radioactivity, by reason of the high
granite content of their soils [64]. Yet, in Galicia excess
risk appears in both sexes, whilst in Extremadura it
appears solely in women.
Finally, different infectious agents have likewise been
implicated in the aetiology of oesophageal cancer.
Whereas infection with Helicobacter pylori, an estab-
lished carcinogen for gastric cancer, has been associated
with reduced risk of oesophageal AC [20], it has also been
proposed as a risk factor for oesophageal SCC [65]. Con-
cerning other infectious agents, some studies have sug-
gested that oesophageal human papillomavirus (HPV)
infection may be implicated in the development of
oesophageal SCC, particularly in high risk areas, in associ-
ation with known risk factors [66-68] though other stud-
ies have found no evidence of a positive association
between HPV infection and either form of oesophageal
cancer [69]. An association between herpes simplex and
Epstein-Barr viruses and oesophageal carcinoma has also
been reported in a high-incidence population in China
[70]. Though the responsibility of infectious agents in the
aetiology of this tumour is yet to be established, it would
be an interesting issue to explore in high risk areas in
Spain. At present, information of the prevalence of these
agents is absent for most Spanish regions.
Conclusion
The excess risks observed in Galicia, Cadiz and the Canary
Islands for both sexes, suggest that the related risk factors
could be different to those implicated in the excesses
detected in Asturias, Cantabria, the Basque Country, Nav-
arre or the north of Castile & León, which only affect
males, and those in Extremadura or the coastal areas of
Malaga and Granada, where the excess risks only affect
women. Among men, the important differences point,
above all, to variations in alcohol and tobacco consump-
tion, including the fact that differing tobacco and alcohol
use patterns might be responsible for part of the differ-
ences. Among women, differences in the prevalence of
obesity, in tandem with different smoking, alcohol use
and dietary patterns, might explain, at least in part, the
variations in risk linked to geographical area. The possible
implication of environmental factors, e.g., drinking water,
and infectious agents cannot be ignored. This type of
study can serve: to detect areas in which greater stress
should be laid on prevention and early detection; and to
stimulate further epidemiological study of specific situa-
tions.
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